Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study

Autor: Smith, B. Douglas, Brümmendorf, Tim H., Roboz, Gail J., Gambacorti-Passerini, Carlo, Charbonnier, Aude, Viqueira, Andrea, Leip, Eric, Purcell, Simon, Goldman, Erinn Hoag, Giles, Francis, Ernst, Thomas, Hochhaus, Andreas, Rosti, Gianantonio
Zdroj: In Leukemia Research April 2024 139
Databáze: ScienceDirect
Externí odkaz: